![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Department of Physiology (G.S., J.C., M.C.S.) and Biology (N.S.), University of Utah, Salt Lake City, Utah; Molecular Systems, Merck Research Laboratories, West Point, Pennsylvania (C.C.); and Cardiovascular Diseases, Aventis Pharma Deutschland GmbH, Frankfurt am Main, Germany (C.L.)
KCNQ1 channels underlie the slow delayed rectifier K+ current, mediate repolarization of cardiac action potentials, and are a potential therapeutic target for treatment of arrhythmia. (E)-(+)-N-[(3R)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(2,4-dichlorophenyl)-2-propenamide [L-735821 (L-7)] is a potent blocker of KCNQ1 channels. Here we describe the structural determinants of KCNQ1 that are critical for high-affinity block by L-7 using site-directed mutagenesis to alter specific residues and voltage clamp to record channel currents in Xenopus laevis oocytes. Chimeric channels were constructed by combination of regions from L-7–sensitive KCNQ1 and L-7–insensitive KCNQ2 channel subunits. This approach localized the drug interaction site to the pore and S6 domains of KCNQ1. Substitution of single amino acids identified Thr-312 of the pore domain and Ile-337, Phe-339, Phe-340, and Ala-344 of the S6 domain as the most important molecular determinants of channel block. Some mutations also altered the inactivation properties of KCNQ1, but there was no correlation between extent of inactivation and sensitivity to block by L-7. Modeling was used to simulate the docking of L-7 to the KCNQ1 channel pore. The docking was consistent with our experimental data and predicts that L-7 blocks K+ conductance by physically precluding the occupancy of a K+ ion to a pore helix-coordinated site within the central hydrated cavity, a crucial step in ion permeation.
Address correspondence to: Michael C. Sanguinetti, Department of Physiology, Eccles Institute of Human Genetics, University of Utah, 15 N 2030 E, Room 4220, Salt Lake City, UT 84112. E-mail: michael.sanguinetti{at}hmbg.utah.edu
This article has been cited by other articles:
|
|
 |
|
  G. C. L. Bett and R. L. Rasmusson Modification of K+ channel-drug interactions by ancillary subunits J. Physiol., February 15, 2008; 586(4): 929 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Cheng, K. Kinard, R. Rajamani, and M. C. Sanguinetti Molecular Mapping of the Binding Site for a Blocker of Hyperpolarization-Activated, Cyclic Nucleotide-Modulated Pacemaker Channels J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 931 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lerche, I. Bruhova, H. Lerche, K. Steinmeyer, A. D. Wei, N. Strutz-Seebohm, F. Lang, A. E. Busch, B. S. Zhorov, and G. Seebohm Chromanol 293B Binding in KCNQ1 (Kv7.1) Channels Involves Electrostatic Interactions with a Potassium Ion in the Selectivity Filter Mol. Pharmacol., June 1, 2007; 71(6): 1503 - 1511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. L. Bett, M. J. Morales, D. L. Beahm, M. E. Duffey, and R. L. Rasmusson Ancillary subunits and stimulation frequency determine the potency of chromanol 293B block of the KCNQ1 potassium channel J. Physiol., November 1, 2006; 576(3): 755 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Decher, P. Kumar, T. Gonzalez, B. Pirard, and M. C. Sanguinetti Binding Site of a Novel Kv1.5 Blocker: A "Foot in the Door" against Atrial Fibrillation Mol. Pharmacol., October 1, 2006; 70(4): 1204 - 1211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Rossokhin, G. Teodorescu, S. Grissmer, and B. S. Zhorov Interaction of d-Tubocurarine with Potassium Channels: Molecular Modeling and Ligand Binding Mol. Pharmacol., April 1, 2006; 69(4): 1356 - 1365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Seebohm, N. Strutz-Seebohm, O. N. Ureche, R. Baltaev, A. Lampert, G. Kornichuk, K. Kamiya, T. V. Wuttke, H. Lerche, M. C. Sanguinetti, et al. Differential Roles of S6 Domain Hinges in the Gating of KCNQ Potassium Channels Biophys. J., March 15, 2006; 90(6): 2235 - 2244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Thomas, A.-B. Wimmer, C. A. Karle, M. Licka, M. Alter, M. Khalil, H. E. Ulmer, S. Kathofer, J. Kiehn, H. A. Katus, et al. Dominant-negative IKs suppression by KCNQ1-{Delta}F339 potassium channels linked to Romano-Ward syndrome Cardiovasc Res, August 15, 2005; 67(3): 487 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Herrera, A. Mamarbachi, M. Simoes, L. Parent, R. Sauve, Z. Wang, and S. Nattel A Single Residue in the S6 Transmembrane Domain Governs the Differential Flecainide Sensitivity of Voltage-Gated Potassium Channels Mol. Pharmacol., August 1, 2005; 68(2): 305 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Strutz-Seebohm, G. Seebohm, A. F. Mack, H.-J. Wagner, L. Just, T. Skutella, U. E. Lang, G. Henke, M. Striegel, M. Hollmann, et al. Regulation of GluR1 abundance in murine hippocampal neurones by serum- and glucocorticoid-inducible kinase 3 J. Physiol., June 1, 2005; 565(2): 381 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Clancy and R. S. Kass Inherited and Acquired Vulnerability to Ventricular Arrhythmias: Cardiac Na+ and K+ Channels Physiol Rev, January 1, 2005; 85(1): 33 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tamargo, R. Caballero, R. Gomez, C. Valenzuela, and E. Delpon Pharmacology of cardiac potassium channels Cardiovasc Res, April 1, 2004; 62(1): 9 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Decher, B. Pirard, F. Bundis, S. Peukert, K.-H. Baringhaus, A. E. Busch, K. Steinmeyer, and M. C. Sanguinetti Molecular Basis for Kv1.5 Channel Block: CONSERVATION OF DRUG BINDING SITES AMONG VOLTAGE-GATED K+ CHANNELS J. Biol. Chem., January 2, 2004; 279(1): 394 - 400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Seebohm, M. Pusch, J. Chen, and M. C. Sanguinetti Pharmacological Activation of Normal and Arrhythmia-Associated Mutant KCNQ1 Potassium Channels Circ. Res., November 14, 2003; 93(10): 941 - 947. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
